The transverse and vertical distribution of prostate cancer in biopsy and radical prostatectomy specimens
Prostate biopsy is the most common method for the diagnosis of prostate cancer and the basis for further treatment. Confirmation using radical prostatectomy specimens is the most reliable method for verifying the accuracy of template-guided transperineal prostate biopsy. The study aimed to reveal th...
Saved in:
Published in | BMC cancer Vol. 18; no. 1; pp. 1205 - 6 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
04.12.2018
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Prostate biopsy is the most common method for the diagnosis of prostate cancer and the basis for further treatment. Confirmation using radical prostatectomy specimens is the most reliable method for verifying the accuracy of template-guided transperineal prostate biopsy. The study aimed to reveal the spatial distribution of prostate cancer in template-guided transperineal saturation biopsy and radical prostatectomy specimens.
Between December 2012 to December 2016, 171 patients were diagnosed with prostate cancer via template-guided transperineal prostate biopsy and subsequently underwent laparoscopic radical prostatectomy. The spatial distributions of prostate cancer were analyzed and the consistency of the tumor distribution between biopsy and radical prostatectomy specimens were compared.
The positive rate of biopsy in the apex region was significantly higher than that of the other biopsy regions (43% vs 28%, P < 0.01). In radical prostatectomy specimens, the positive rate was highest at the region 0.9-1.3 cm above the apex, and it had a tendency to decrease towards the base. There was a significant difference in the positive rate between the cephalic and caudal half of the prostate (68% vs 99%, P < 0.01). There were no significant differences between the anterior and posterior zones for either biopsy or radical prostatectomy specimens.
The tumor spatial distribution generated by template-guided transperineal prostate biopsy was consistent with that of radical prostatectomy specimens in general. The positive rate was consistent between anterior and posterior zones. The caudal half of the prostate, especially the vicinity of the apex, was the frequently occurred site of the tumor. |
---|---|
AbstractList | Background Prostate biopsy is the most common method for the diagnosis of prostate cancer and the basis for further treatment. Confirmation using radical prostatectomy specimens is the most reliable method for verifying the accuracy of template-guided transperineal prostate biopsy. The study aimed to reveal the spatial distribution of prostate cancer in template-guided transperineal saturation biopsy and radical prostatectomy specimens. Methods Between December 2012 to December 2016, 171 patients were diagnosed with prostate cancer via template-guided transperineal prostate biopsy and subsequently underwent laparoscopic radical prostatectomy. The spatial distributions of prostate cancer were analyzed and the consistency of the tumor distribution between biopsy and radical prostatectomy specimens were compared. Results The positive rate of biopsy in the apex region was significantly higher than that of the other biopsy regions (43% vs 28%, P < 0.01). In radical prostatectomy specimens, the positive rate was highest at the region 0.9-1.3 cm above the apex, and it had a tendency to decrease towards the base. There was a significant difference in the positive rate between the cephalic and caudal half of the prostate (68% vs 99%, P < 0.01). There were no significant differences between the anterior and posterior zones for either biopsy or radical prostatectomy specimens. Conclusion The tumor spatial distribution generated by template-guided transperineal prostate biopsy was consistent with that of radical prostatectomy specimens in general. The positive rate was consistent between anterior and posterior zones. The caudal half of the prostate, especially the vicinity of the apex, was the frequently occurred site of the tumor. Keywords: Spatial distribution, Biopsy, Radical prostatectomy, Apex Abstract Background Prostate biopsy is the most common method for the diagnosis of prostate cancer and the basis for further treatment. Confirmation using radical prostatectomy specimens is the most reliable method for verifying the accuracy of template-guided transperineal prostate biopsy. The study aimed to reveal the spatial distribution of prostate cancer in template-guided transperineal saturation biopsy and radical prostatectomy specimens. Methods Between December 2012 to December 2016, 171 patients were diagnosed with prostate cancer via template-guided transperineal prostate biopsy and subsequently underwent laparoscopic radical prostatectomy. The spatial distributions of prostate cancer were analyzed and the consistency of the tumor distribution between biopsy and radical prostatectomy specimens were compared. Results The positive rate of biopsy in the apex region was significantly higher than that of the other biopsy regions (43% vs 28%, P < 0.01). In radical prostatectomy specimens, the positive rate was highest at the region 0.9–1.3 cm above the apex, and it had a tendency to decrease towards the base. There was a significant difference in the positive rate between the cephalic and caudal half of the prostate (68% vs 99%, P < 0.01). There were no significant differences between the anterior and posterior zones for either biopsy or radical prostatectomy specimens. Conclusion The tumor spatial distribution generated by template-guided transperineal prostate biopsy was consistent with that of radical prostatectomy specimens in general. The positive rate was consistent between anterior and posterior zones. The caudal half of the prostate, especially the vicinity of the apex, was the frequently occurred site of the tumor. Background Prostate biopsy is the most common method for the diagnosis of prostate cancer and the basis for further treatment. Confirmation using radical prostatectomy specimens is the most reliable method for verifying the accuracy of template-guided transperineal prostate biopsy. The study aimed to reveal the spatial distribution of prostate cancer in template-guided transperineal saturation biopsy and radical prostatectomy specimens. Methods Between December 2012 to December 2016, 171 patients were diagnosed with prostate cancer via template-guided transperineal prostate biopsy and subsequently underwent laparoscopic radical prostatectomy. The spatial distributions of prostate cancer were analyzed and the consistency of the tumor distribution between biopsy and radical prostatectomy specimens were compared. Results The positive rate of biopsy in the apex region was significantly higher than that of the other biopsy regions (43% vs 28%, P < 0.01). In radical prostatectomy specimens, the positive rate was highest at the region 0.9–1.3 cm above the apex, and it had a tendency to decrease towards the base. There was a significant difference in the positive rate between the cephalic and caudal half of the prostate (68% vs 99%, P < 0.01). There were no significant differences between the anterior and posterior zones for either biopsy or radical prostatectomy specimens. Conclusion The tumor spatial distribution generated by template-guided transperineal prostate biopsy was consistent with that of radical prostatectomy specimens in general. The positive rate was consistent between anterior and posterior zones. The caudal half of the prostate, especially the vicinity of the apex, was the frequently occurred site of the tumor. Prostate biopsy is the most common method for the diagnosis of prostate cancer and the basis for further treatment. Confirmation using radical prostatectomy specimens is the most reliable method for verifying the accuracy of template-guided transperineal prostate biopsy. The study aimed to reveal the spatial distribution of prostate cancer in template-guided transperineal saturation biopsy and radical prostatectomy specimens. Between December 2012 to December 2016, 171 patients were diagnosed with prostate cancer via template-guided transperineal prostate biopsy and subsequently underwent laparoscopic radical prostatectomy. The spatial distributions of prostate cancer were analyzed and the consistency of the tumor distribution between biopsy and radical prostatectomy specimens were compared. The positive rate of biopsy in the apex region was significantly higher than that of the other biopsy regions (43% vs 28%, P < 0.01). In radical prostatectomy specimens, the positive rate was highest at the region 0.9-1.3 cm above the apex, and it had a tendency to decrease towards the base. There was a significant difference in the positive rate between the cephalic and caudal half of the prostate (68% vs 99%, P < 0.01). There were no significant differences between the anterior and posterior zones for either biopsy or radical prostatectomy specimens. The tumor spatial distribution generated by template-guided transperineal prostate biopsy was consistent with that of radical prostatectomy specimens in general. The positive rate was consistent between anterior and posterior zones. The caudal half of the prostate, especially the vicinity of the apex, was the frequently occurred site of the tumor. Prostate biopsy is the most common method for the diagnosis of prostate cancer and the basis for further treatment. Confirmation using radical prostatectomy specimens is the most reliable method for verifying the accuracy of template-guided transperineal prostate biopsy. The study aimed to reveal the spatial distribution of prostate cancer in template-guided transperineal saturation biopsy and radical prostatectomy specimens. Between December 2012 to December 2016, 171 patients were diagnosed with prostate cancer via template-guided transperineal prostate biopsy and subsequently underwent laparoscopic radical prostatectomy. The spatial distributions of prostate cancer were analyzed and the consistency of the tumor distribution between biopsy and radical prostatectomy specimens were compared. The positive rate of biopsy in the apex region was significantly higher than that of the other biopsy regions (43% vs 28%, P < 0.01). In radical prostatectomy specimens, the positive rate was highest at the region 0.9-1.3 cm above the apex, and it had a tendency to decrease towards the base. There was a significant difference in the positive rate between the cephalic and caudal half of the prostate (68% vs 99%, P < 0.01). There were no significant differences between the anterior and posterior zones for either biopsy or radical prostatectomy specimens. The tumor spatial distribution generated by template-guided transperineal prostate biopsy was consistent with that of radical prostatectomy specimens in general. The positive rate was consistent between anterior and posterior zones. The caudal half of the prostate, especially the vicinity of the apex, was the frequently occurred site of the tumor. Prostate biopsy is the most common method for the diagnosis of prostate cancer and the basis for further treatment. Confirmation using radical prostatectomy specimens is the most reliable method for verifying the accuracy of template-guided transperineal prostate biopsy. The study aimed to reveal the spatial distribution of prostate cancer in template-guided transperineal saturation biopsy and radical prostatectomy specimens.BACKGROUNDProstate biopsy is the most common method for the diagnosis of prostate cancer and the basis for further treatment. Confirmation using radical prostatectomy specimens is the most reliable method for verifying the accuracy of template-guided transperineal prostate biopsy. The study aimed to reveal the spatial distribution of prostate cancer in template-guided transperineal saturation biopsy and radical prostatectomy specimens.Between December 2012 to December 2016, 171 patients were diagnosed with prostate cancer via template-guided transperineal prostate biopsy and subsequently underwent laparoscopic radical prostatectomy. The spatial distributions of prostate cancer were analyzed and the consistency of the tumor distribution between biopsy and radical prostatectomy specimens were compared.METHODSBetween December 2012 to December 2016, 171 patients were diagnosed with prostate cancer via template-guided transperineal prostate biopsy and subsequently underwent laparoscopic radical prostatectomy. The spatial distributions of prostate cancer were analyzed and the consistency of the tumor distribution between biopsy and radical prostatectomy specimens were compared.The positive rate of biopsy in the apex region was significantly higher than that of the other biopsy regions (43% vs 28%, P < 0.01). In radical prostatectomy specimens, the positive rate was highest at the region 0.9-1.3 cm above the apex, and it had a tendency to decrease towards the base. There was a significant difference in the positive rate between the cephalic and caudal half of the prostate (68% vs 99%, P < 0.01). There were no significant differences between the anterior and posterior zones for either biopsy or radical prostatectomy specimens.RESULTSThe positive rate of biopsy in the apex region was significantly higher than that of the other biopsy regions (43% vs 28%, P < 0.01). In radical prostatectomy specimens, the positive rate was highest at the region 0.9-1.3 cm above the apex, and it had a tendency to decrease towards the base. There was a significant difference in the positive rate between the cephalic and caudal half of the prostate (68% vs 99%, P < 0.01). There were no significant differences between the anterior and posterior zones for either biopsy or radical prostatectomy specimens.The tumor spatial distribution generated by template-guided transperineal prostate biopsy was consistent with that of radical prostatectomy specimens in general. The positive rate was consistent between anterior and posterior zones. The caudal half of the prostate, especially the vicinity of the apex, was the frequently occurred site of the tumor.CONCLUSIONThe tumor spatial distribution generated by template-guided transperineal prostate biopsy was consistent with that of radical prostatectomy specimens in general. The positive rate was consistent between anterior and posterior zones. The caudal half of the prostate, especially the vicinity of the apex, was the frequently occurred site of the tumor. |
ArticleNumber | 1205 |
Audience | Academic |
Author | Li, Hanzhong Liang, Zhiyong Mai, Zhipeng Xiao, Yu Yan, Weigang Zhou, Zhien Zhou, Yi Ji, Zhigang |
Author_xml | – sequence: 1 givenname: Zhipeng surname: Mai fullname: Mai, Zhipeng – sequence: 2 givenname: Zhien surname: Zhou fullname: Zhou, Zhien – sequence: 3 givenname: Weigang surname: Yan fullname: Yan, Weigang – sequence: 4 givenname: Yu surname: Xiao fullname: Xiao, Yu – sequence: 5 givenname: Yi surname: Zhou fullname: Zhou, Yi – sequence: 6 givenname: Zhiyong surname: Liang fullname: Liang, Zhiyong – sequence: 7 givenname: Zhigang surname: Ji fullname: Ji, Zhigang – sequence: 8 givenname: Hanzhong surname: Li fullname: Li, Hanzhong |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30514243$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kl1v0zAYhSM0xLbCD-AGRUJCcJHhz9i-QZomPipNQoJxbTm207pK7WI7E_33uO0KzQTKhS37OSd5T85ldeaDt1X1EoIrCHn7PkHEOW0A5A2FiDTiSXUBCYMNIoCdnezPq8uUVgBAxgF_Vp1jQCFBBF9U7m5p6xyVT_c2Jlsrb-qyy06roTYu5ei6Mbvg69DXmxhSVtnWWnltY-183bmwSdu9LCqzVx0pncN6W6eN1W5tfXpePe3VkOyLh3VW_fj08e7mS3P79fP85vq20S2iuTHU9KxHneC2xYhZwChFWHUIM6g5Mp3hHcOoU0JwLSBpNeNEkJZhzm1nGZ5V84OvCWolN9GtVdzKoJzcH4S4kGo332AlMcQCojToqSLACKEF6EnPIcJYob4tXh8OXpuxW1ujrS9RDRPT6Y13S7kI97JFJWmBi8HbB4MYfo42Zbl2SdthUN6GMUkEKaCYijLirHr9CF2FMfoS1Y7ipPwzzv9SC1UGcL4P5b16ZyqvactbIFpOC3X1D6o8xq6dLiXqXTmfCN5NBIXJ9ldeqDElOf_-bcq-OWGXVg15mcKwb0magq9O0_sT27F9BWAHQJfKpGh7qV1pTvEpn-sGCYHc9Vweei5Lz-Wu51IUJXykPJr_X_Mbd_n9dA |
CitedBy_id | crossref_primary_10_4143_crt_2019_716 crossref_primary_10_1016_j_urolonc_2021_04_021 crossref_primary_10_1038_s41391_023_00714_x crossref_primary_10_1038_s41391_020_0205_7 crossref_primary_10_1002_jmri_27138 crossref_primary_10_1007_s00345_023_04729_w crossref_primary_10_1007_s00259_021_05636_1 crossref_primary_10_4103_iju_iju_36_24 crossref_primary_10_1007_s00345_022_04102_3 crossref_primary_10_1038_s41391_023_00729_4 crossref_primary_10_1186_s40644_022_00516_9 crossref_primary_10_17650_1726_9776_2021_17_2_157_167 crossref_primary_10_1159_000520373 crossref_primary_10_1002_pros_24091 crossref_primary_10_1016_j_euf_2023_01_016 crossref_primary_10_1016_j_xinn_2023_100558 crossref_primary_10_1007_s00345_024_05202_y |
Cites_doi | 10.1111/bju.13024 10.1016/j.urology.2007.07.072 10.1016/S0360-3016(98)00434-9 10.1007/s11255-016-1484-8 10.1002/pros.22622 10.1016/j.eururo.2014.08.077 10.1016/j.juro.2012.01.066 10.1002/pros.22975 10.1097/COC.0000000000000105 10.1007/s11255-016-1283-2 10.1046/j.1464-410X.2002.02796.x 10.1016/j.eururo.2015.12.015 10.1016/j.eururo.2013.09.045 10.1002/pros.10298 10.1038/nrurol.2013.195 10.1016/j.urolonc.2014.10.006 10.1016/j.urolonc.2008.05.002 10.1016/j.eururo.2014.09.018 10.1016/j.urology.2017.02.027 10.1016/j.eururo.2015.01.030 10.1016/S1470-2045(12)70121-3 10.1016/j.juro.2013.02.021 10.1016/S1470-2045(16)30661-1 10.1002/ijc.2910200506 10.1111/bju.12458 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2018 BioMed Central Ltd. Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s). 2018 |
Copyright_xml | – notice: COPYRIGHT 2018 BioMed Central Ltd. – notice: Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s). 2018 |
DBID | AAYXX CITATION NPM ISR 3V. 7TO 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12885-018-5124-9 |
DatabaseName | CrossRef PubMed Gale In Context: Science ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1471-2407 |
EndPage | 6 |
ExternalDocumentID | oai_doaj_org_article_4d4e04ac0f5a40d99c90f4f81233a2f6 PMC6278093 A568609685 30514243 10_1186_s12885_018_5124_9 |
Genre | Journal Article |
GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR IHW INH INR ISR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB NPM PMFND 3V. 7TO 7XB 8FK AZQEC DWQXO H94 K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c625t-d5df7f2b98e6327e075523ab2371c82dbd8b732ba998c9146c7849467388ebe73 |
IEDL.DBID | M48 |
ISSN | 1471-2407 |
IngestDate | Wed Aug 27 01:06:06 EDT 2025 Thu Aug 21 14:10:27 EDT 2025 Tue Aug 05 09:45:20 EDT 2025 Fri Jul 25 10:01:32 EDT 2025 Tue Jun 17 21:39:17 EDT 2025 Tue Jun 10 20:18:25 EDT 2025 Fri Jun 27 04:16:35 EDT 2025 Thu May 22 21:01:07 EDT 2025 Thu Apr 03 06:57:33 EDT 2025 Thu Apr 24 22:59:01 EDT 2025 Tue Jul 01 03:06:11 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Spatial distribution Radical prostatectomy Biopsy Apex |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c625t-d5df7f2b98e6327e075523ab2371c82dbd8b732ba998c9146c7849467388ebe73 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12885-018-5124-9 |
PMID | 30514243 |
PQID | 2158430588 |
PQPubID | 44074 |
PageCount | 6 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_4d4e04ac0f5a40d99c90f4f81233a2f6 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6278093 proquest_miscellaneous_2150535952 proquest_journals_2158430588 gale_infotracmisc_A568609685 gale_infotracacademiconefile_A568609685 gale_incontextgauss_ISR_A568609685 gale_healthsolutions_A568609685 pubmed_primary_30514243 crossref_citationtrail_10_1186_s12885_018_5124_9 crossref_primary_10_1186_s12885_018_5124_9 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-12-04 |
PublicationDateYYYYMMDD | 2018-12-04 |
PublicationDate_xml | – month: 12 year: 2018 text: 2018-12-04 day: 04 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC cancer |
PublicationTitleAlternate | BMC Cancer |
PublicationYear | 2018 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | AR Azzouzi (5124_CR11) 2017; 18 DT Chang (5124_CR3) 2013; 10 T Furuno (5124_CR19) 2004; 58 A Sivaraman (5124_CR15) 2016; 69 AV D’Amico (5124_CR8) 1999; 43 IA Donaldson (5124_CR1) 2015; 67 GS Merrick (5124_CR2) 2015; 40 E Baco (5124_CR23) 2015; 67 H Li (5124_CR6) 2007; 70 N Breslow (5124_CR16) 1997; 20 AS Huo (5124_CR21) 2012; 187 M Perera (5124_CR9) 2014; 113 N Bittner (5124_CR17) 2013; 190 J Gordetsky (5124_CR24) 2017; 105 W Yan (5124_CR5) 2009; 27 ED Crawford (5124_CR7) 2013; 73 HU Ahmed (5124_CR12) 2012; 13 SR Bott (5124_CR18) 2002; 89 PB Singh (5124_CR14) 2014; 66 HU Ahmed (5124_CR13) 2015; 68 WJ Ven van de (5124_CR25) 2016; 48 Z Mai (5124_CR4) 2016; 117 M Kido (5124_CR20) 2015; 75 A Richters (5124_CR10) 2015; 33 Q Zhang (5124_CR22) 2017; 49 22498226 - J Urol. 2012 Jun;187(6):2044-9 28238758 - Urology. 2017 Jul;105:18-23 14673955 - Prostate. 2004 Jan 1;58(1):76-81 24061531 - Nat Rev Urol. 2013 Dec;10(12):690-702 25523314 - BJU Int. 2016 Mar;117(3):424-9 23169245 - Prostate. 2013 May;73(7):778-87 23416641 - J Urol. 2013 Aug;190(2):509-14 27068817 - Int Urol Nephrol. 2016 Jul;48(7):1037-45 22512844 - Lancet Oncol. 2012 Jun;13(6):622-32 26778462 - Eur Urol. 2016 Jun;69(6):973-5 28005230 - Int Urol Nephrol. 2017 Mar;49(3):439-448 12010233 - BJU Int. 2002 Jun;89(9):886-9 25456999 - Urol Oncol. 2015 Jan;33(1):16.e9-16.e15 25682339 - Eur Urol. 2015 Dec;68(6):927-36 924691 - Int J Cancer. 1977 Nov 15;20(5):680-8 24053510 - BJU Int. 2014 Mar;113 Suppl 2:29-34 28007457 - Lancet Oncol. 2017 Feb;18(2):181-191 18625566 - Urol Oncol. 2009 Sep-Oct;27(5):520-4 25728717 - Prostate. 2015 Jun 15;75(9):917-22 24207133 - Eur Urol. 2014 Jul;66(1):12-9 18158038 - Urology. 2007 Dec;70(6):1157-61 25281389 - Eur Urol. 2015 Apr;67(4):771-7 25068472 - Am J Clin Oncol. 2017 Feb;40(1):53-59 25240973 - Eur Urol. 2015 Apr;67(4):787-94 10078642 - Int J Radiat Oncol Biol Phys. 1999 Feb 1;43(3):587-90 |
References_xml | – volume: 117 start-page: 424 issue: 3 year: 2016 ident: 5124_CR4 publication-title: BJU Int doi: 10.1111/bju.13024 – volume: 70 start-page: 1157 issue: 6 year: 2007 ident: 5124_CR6 publication-title: Urology doi: 10.1016/j.urology.2007.07.072 – volume: 43 start-page: 587 issue: 3 year: 1999 ident: 5124_CR8 publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/S0360-3016(98)00434-9 – volume: 49 start-page: 439 issue: 3 year: 2017 ident: 5124_CR22 publication-title: Int Urol Nephrol doi: 10.1007/s11255-016-1484-8 – volume: 73 start-page: 778 issue: 7 year: 2013 ident: 5124_CR7 publication-title: Prostate doi: 10.1002/pros.22622 – volume: 67 start-page: 787 issue: 4 year: 2015 ident: 5124_CR23 publication-title: Eur Urol doi: 10.1016/j.eururo.2014.08.077 – volume: 187 start-page: 2044 issue: 6 year: 2012 ident: 5124_CR21 publication-title: J Urol doi: 10.1016/j.juro.2012.01.066 – volume: 75 start-page: 917 issue: 9 year: 2015 ident: 5124_CR20 publication-title: Prostate doi: 10.1002/pros.22975 – volume: 40 start-page: 53 issue: 1 year: 2015 ident: 5124_CR2 publication-title: Am J Clin Oncol doi: 10.1097/COC.0000000000000105 – volume: 48 start-page: 1037 issue: 7 year: 2016 ident: 5124_CR25 publication-title: Int Urol Nephrol doi: 10.1007/s11255-016-1283-2 – volume: 89 start-page: 886 issue: 9 year: 2002 ident: 5124_CR18 publication-title: BJU Int doi: 10.1046/j.1464-410X.2002.02796.x – volume: 69 start-page: 973 issue: 6 year: 2016 ident: 5124_CR15 publication-title: Eur Urol doi: 10.1016/j.eururo.2015.12.015 – volume: 66 start-page: 12 issue: 1 year: 2014 ident: 5124_CR14 publication-title: Eur Urol doi: 10.1016/j.eururo.2013.09.045 – volume: 58 start-page: 76 issue: 1 year: 2004 ident: 5124_CR19 publication-title: Prostate doi: 10.1002/pros.10298 – volume: 10 start-page: 690 issue: 12 year: 2013 ident: 5124_CR3 publication-title: Nat Rev Urol doi: 10.1038/nrurol.2013.195 – volume: 33 start-page: 16.e9 issue: 1 year: 2015 ident: 5124_CR10 publication-title: Urol Oncol doi: 10.1016/j.urolonc.2014.10.006 – volume: 27 start-page: 520 issue: 5 year: 2009 ident: 5124_CR5 publication-title: Urol Oncol doi: 10.1016/j.urolonc.2008.05.002 – volume: 67 start-page: 771 issue: 4 year: 2015 ident: 5124_CR1 publication-title: Eur Urol doi: 10.1016/j.eururo.2014.09.018 – volume: 105 start-page: 18 year: 2017 ident: 5124_CR24 publication-title: Urology doi: 10.1016/j.urology.2017.02.027 – volume: 68 start-page: 927 issue: 6 year: 2015 ident: 5124_CR13 publication-title: Eur Urol doi: 10.1016/j.eururo.2015.01.030 – volume: 13 start-page: 622 issue: 6 year: 2012 ident: 5124_CR12 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(12)70121-3 – volume: 190 start-page: 509 issue: 2 year: 2013 ident: 5124_CR17 publication-title: J Urol doi: 10.1016/j.juro.2013.02.021 – volume: 18 start-page: 181 issue: 2 year: 2017 ident: 5124_CR11 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(16)30661-1 – volume: 20 start-page: 680 issue: 5 year: 1997 ident: 5124_CR16 publication-title: Int J Cancer doi: 10.1002/ijc.2910200506 – volume: 113 start-page: 29 issue: Suppl 2 year: 2014 ident: 5124_CR9 publication-title: BJU Int doi: 10.1111/bju.12458 – reference: 25281389 - Eur Urol. 2015 Apr;67(4):771-7 – reference: 28005230 - Int Urol Nephrol. 2017 Mar;49(3):439-448 – reference: 10078642 - Int J Radiat Oncol Biol Phys. 1999 Feb 1;43(3):587-90 – reference: 924691 - Int J Cancer. 1977 Nov 15;20(5):680-8 – reference: 24061531 - Nat Rev Urol. 2013 Dec;10(12):690-702 – reference: 25456999 - Urol Oncol. 2015 Jan;33(1):16.e9-16.e15 – reference: 25728717 - Prostate. 2015 Jun 15;75(9):917-22 – reference: 18625566 - Urol Oncol. 2009 Sep-Oct;27(5):520-4 – reference: 25682339 - Eur Urol. 2015 Dec;68(6):927-36 – reference: 25068472 - Am J Clin Oncol. 2017 Feb;40(1):53-59 – reference: 22498226 - J Urol. 2012 Jun;187(6):2044-9 – reference: 28238758 - Urology. 2017 Jul;105:18-23 – reference: 14673955 - Prostate. 2004 Jan 1;58(1):76-81 – reference: 28007457 - Lancet Oncol. 2017 Feb;18(2):181-191 – reference: 26778462 - Eur Urol. 2016 Jun;69(6):973-5 – reference: 18158038 - Urology. 2007 Dec;70(6):1157-61 – reference: 27068817 - Int Urol Nephrol. 2016 Jul;48(7):1037-45 – reference: 12010233 - BJU Int. 2002 Jun;89(9):886-9 – reference: 24053510 - BJU Int. 2014 Mar;113 Suppl 2:29-34 – reference: 25523314 - BJU Int. 2016 Mar;117(3):424-9 – reference: 22512844 - Lancet Oncol. 2012 Jun;13(6):622-32 – reference: 25240973 - Eur Urol. 2015 Apr;67(4):787-94 – reference: 23416641 - J Urol. 2013 Aug;190(2):509-14 – reference: 24207133 - Eur Urol. 2014 Jul;66(1):12-9 – reference: 23169245 - Prostate. 2013 May;73(7):778-87 |
SSID | ssj0017808 |
Score | 2.3633687 |
Snippet | Prostate biopsy is the most common method for the diagnosis of prostate cancer and the basis for further treatment. Confirmation using radical prostatectomy... Background Prostate biopsy is the most common method for the diagnosis of prostate cancer and the basis for further treatment. Confirmation using radical... Abstract Background Prostate biopsy is the most common method for the diagnosis of prostate cancer and the basis for further treatment. Confirmation using... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1205 |
SubjectTerms | Accuracy Apex Biopsy Cancer patients Cancer surgery Cancer therapies Care and treatment Comparative analysis Diagnosis Health aspects Laparoscopy Metastasis Methods NMR Nuclear magnetic resonance Prostate biopsy Prostate cancer Prostatectomy Radical prostatectomy Spatial distribution Ultrasonic imaging Urological surgery Vertical distribution |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA9yD-KL-G311CiCIJTrJmmbPJ7icQrng3pwbyGfuqDtsu0-3H_vTJotWwR98XUzA935yMyQmd8Q8tpXVWxXVpTe8aoU0prSrpQpaxkrFRyORuKg8MXn5vxSfLqqrw5WfWFP2AQPPAnuRHgRKmFcFWsjKq-UU1UUEeIS54bFBLYNMW9fTOX3g1ZWMr9hrmRzMsAtLLFJTZYQ4ESpFlEogfX_eSUfxKRlv-RBADq7Q27nzJGeTl98l9wI3T1y8yK_jd8na9A4HTH0YKdFoKbzNC1bBi1Qj_i4ebUV7SPd4LAHpJnUoda3dN1Ru-43w3Vi25r0ejNTubH_dU1xKBN3AQwPyOXZh2_vz8u8SKF0UN6Mpa99bCOzSoaGszZAmgD1p7GMtysnmbde2pYza6D2cgruTtdKoQQuBJWg5JY_JEdd34XHhMYoRB0MSN4YIZSTkSnDbIi1tSxGVZBqL1jtMso4Lrv4qVO1IRs96UKDLjTqQgPL25llM0Fs_I34HWprJkR07PQD2IzONqP_ZTMFeYG61tOo6ezj-rRuZAM1nawL8ipRIEJGhy04381uGPTHr18WRG8yUezhPzqTJxpAUgiqtaA8XlCCC7vl8d7odL5CBg25mEQ8NikL8nI-Rk5si-tCv0s0iM-jalaQR5ONzpLhiGzPBC9Iu7DeheiWJ936RwIYbxj4j-JP_oesn5JbDP0OO4DEMTkat7vwDPK40T5PLvsb2vlF1g priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96gvgiftvz1CiCIJRr07RNnuQUj1M4H9SDfQv5vFvQdm_bfbj_3plstl4R7rWZQJtfZibTzPyGkHeuKEJbGp47WxU5F0bnppQ6r0UopLdYGomFwqffm5Mz_m1RL9IPtyGlVe5sYjTUrrf4j_wQXJNAeiohPq4uc-wahberqYXGbXIHqcswpatdTAFX2YpCpJvMUjSHA9higalqIgc3x3M580WRsv9_w3zNM82zJq-5oeMH5H46P9KjLeAPyS3fPSJ3T9MN-WOyBNzpiA4I8y081Z2jseUyYEEdsuSmBle0D3SFJR9w2KQWsV_TZUfNsl8NV3HaWsc7nEnKjv2fK4qlmdgRYHhCzo6__Pp8kqd2CrmFIGfMXe1CG5iRwjcVaz0cFiAK1YZVbWkFc8YJ01bMaIjArAQLalvBJce2oAKgbqunZK_rO_-c0BA4r73WLGjNubQiMKmZ8aE2hoUgM1LsFlbZxDWOLS9-qxhziEZtsVCAhUIsFEz5ME1ZbYk2bhL-hGhNgsiRHR_063OVVE5xx33BtS1CrXnhpLSyCDzAiaaq4M2bjLxGrNW24HTSdHVUN6KByE7UGXkbJZAno8NEnHO9GQb19eePmdD7JBR6-EarU10DrBRSa80kD2aSoMh2PrzbdCoZkkH92_YZeTMN40xMjut8v4kyyNIja5aRZ9s9Oq1Mhfz2jFcZaWe7d7Z085FueRFpxhsG-iOr_Ztf6wW5x1CjMMOHH5C9cb3xL-GcNppXURn_AudRPVM priority: 102 providerName: ProQuest |
Title | The transverse and vertical distribution of prostate cancer in biopsy and radical prostatectomy specimens |
URI | https://www.ncbi.nlm.nih.gov/pubmed/30514243 https://www.proquest.com/docview/2158430588 https://www.proquest.com/docview/2150535952 https://pubmed.ncbi.nlm.nih.gov/PMC6278093 https://doaj.org/article/4d4e04ac0f5a40d99c90f4f81233a2f6 |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9QwEA_3Ace9iN9WzzWKIAjVbpo2yYPIrdxxCnvI6sLhS0jS5lw423W7C-5_70y2W694-ODLPjQz0M3MZGaamd8Q8rJIEi-GlseFS5OYS2tiO1QmzqRPVOmwNRIbhcfn-dmUf7rILnbIdrxVu4HNjakdzpOaLq7e_Pq5fg8G_y4YvMzfNnDGSixBkzG4Lx6rXbIPjkmgnY75n0sFIRPZXmzeyHZIDlKEA2c87XmpAOb_95F9zWf16ymvOajT2-RWG1nS440q3CE7ZXWXHIzbu_N7ZAYaQZfomrASo6SmKmgYxgxSogXi57ajr2jt6RybQSAMpQ61YkFnFbWzet6sA9vChNudjsot6x9rik2bOCuguU-mpydfP5zF7aCF2EH6s4yLrPDCM6tkmadMlBBGQH5qLEvF0ElW2EJakTJrIDdzCs5WJyRXHAeGSlACkT4ge1VdlY8I9Z7zrDSGeWM4V056pgyzpc-sZd6riCTbjdWuRSHHYRhXOmQjMtcbsWgQi0axaGB53bHMNxAc_yIeobQ6QkTPDg_qxaVujVHzgpcJNy7xmeFJoZRTieceYp00hTfPI_IMZa03rajdGaCPs1zmkPPJLCIvAgUiaFRYonNpVk2jP36Z9IhetUS-hv_oTNvxADuFoFs9yqMeJZi46y9vlU5vLURDrCYRr03KiDzvlpETy-aqsl4FGsTvURmLyMONjnY7s1X1iIie9va2rr9Szb4HAPKcgSmp9PF_cz4hhwztDsuC-BHZWy5W5VMI7pZ2QHbFhRiQ_dHJ-efJIHwiGQQzht_J6Ntvn_lSHg |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1db9Mw0BqdBLwgvgkMZhAICSla6jiJ_YDQBptatk5obNLejO3YoxIkpWmF-qf4jdwlaViEtLe91ucque_LfRHyOo8inw0ND3MbRyEXRodmKHWYCB9JZ7E1EhuFJ8fp6Ix_Pk_ON8ifdS8MllWudWKtqPPS4jfyHTBNAsdTCfFh9ivErVGYXV2v0GjY4tCtfkPIVr0ffwL6vmHsYP_04yhstwqEFnz9RZgnuc88M1K4NGaZA5sJwZg2LM6GVrDc5MJkMTMaAhErQZHYTHBcRB8LAW-cxfC_N8gmjyGUGZDNvf3jLydd3iITkWhzp0OR7lSg_QUWx4kQDCsPZc_61UsC_jcFl2xhv07zkuE7uEvutB4r3W1Y7B7ZcMV9cnPS5uQfkClwGl2gycMKD0d1kdN6yTNQn-Y4l7ddqUVLT2fYZALuLbXIbXM6LaiZlrNqVV-b6zpr1EHZRflzRbEZFHcQVA_J2bWg-hEZFGXhnhDqPeeJ05p5rTmXVngmNTPOJ8Yw72VAojVilW2nm-OSjR-qjnJEqhpaKKCFQloouPKuuzJrRntcBbyH1OoAcSp3_UM5v1CtkCuecxdxbSOfaB7lUloZee7Bh4pjePI0INtIa9W0uHa6Re0mqUghlhRJQF7VEDiZo8DSnwu9rCo1_nrSA3rbAvkS3tHqtpMCMIXDvHqQWz1IUB22f7xmOtWqrkr9E7SAvOyO8SaW4xWuXNYwOBdIJiwgjxse7TAT40R9xuOAZD3u7aGuf1JMv9eDzVMG8iPjp1c_1ja5NTqdHKmj8fHhM3KboXRhfRHfIoPFfOmeg5e4MC9a0aTk23Vrg78_F3qM |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+transverse+and+vertical+distribution+of+prostate+cancer+in+biopsy+and+radical+prostatectomy+specimens&rft.jtitle=BMC+cancer&rft.au=Mai%2C+Zhipeng&rft.au=Zhou%2C+Zhien&rft.au=Yan%2C+Weigang&rft.au=Xiao%2C+Yu&rft.date=2018-12-04&rft.pub=BioMed+Central&rft.eissn=1471-2407&rft.volume=18&rft_id=info:doi/10.1186%2Fs12885-018-5124-9&rft_id=info%3Apmid%2F30514243&rft.externalDocID=PMC6278093 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2407&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2407&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2407&client=summon |